Announcing Appointment To TBDWG
Announcing Appointment To TBDWG
The Ego Couldn't Contain Itself
The Ego Couldn't Contain Itself
Two weeks before the meeting scheduled for June 4, 2019 took place, IDSA announced Eugene Shapiro was selected to be on the federal Tick Borne Disease Working Group. There was no official disclosure for additional members until the night before the meeting. When the names were announed the information wasn't on the TBDWG website where all other announcements had been made. Instead it was in the form of a last minute press release that most had no idea had even been issued.
FOR IMMEDIATE RELEASE
Monday, June 3, 2019
Contact: ASH Media Office
(202) 205-0143
The U.S. Department of Health and Human Services announces today the appointment of new members to fill vacant positions on the Tick-Borne Disease Working Group (Working Group). These new members include five Special Government Employees and four Regular Government Employees (RGEs). The Working Group also announces six alternate RGE members, should the RGE members not be able to attend meetings.
The Working Group will hold its next public meeting on June 4, 2019, from 8:30 a.m. to 5:00 p.m. ET, at the Holiday Inn Washington-Capitol, 550 C Street S.W., Washington, D.C. Members of the public may attend the meeting in person or via webcast. For more information, visit the Working Group's website here.
The Tick-Borne Disease Working Group was established on August 10, 2017, as required by the 21st Century Cures Act, to provide expertise and to review all efforts within the Department of Health and Human Services related to all tick-borne diseases, to examine research priorities and to help ensure interagency coordination and minimize overlap. The Working Group is required to submit a report to the HHS Secretary and Congress on their findings and any recommendations for the federal response to tick-borne disease every two years. It issued its first report in November 2018.
The Working Group will be chaired by David Hughes Walker, M.D., Professor of Pathology and Executive Director, University of Texas Medical Branch Center for Biodefense and Emerging Infectious Diseases; and Leigh Ann Soltysiak, Owner, Principal, Silverleaf Consulting, LLC.
The Working Group members are as follows:
SPECIAL GOVERNMENT EMPLOYEES (PUBLIC MEMBERS)
Leigh Ann Soltysiak* (Co-Chair): Owner, Principal, Silverleaf Consulting, LLC; Adjunct Professor, Entrepreneurship Thinking, Stevens Institute of Technology (New Providence, New Jersey). She brings a valuable perspective to the Working Group as a former Lyme disease patient who speaks honestly about the physical, financial and psychosocial issues caused by the disease. She was a valued member of the 2018 Working Group's Vaccines/Therapeutics subcommittee.
David Hughes Walker,* M.D. (Co-Chair): Professor of Pathology, The Carnage and Martha Walls Distinguished University Chair in Tropical Diseases; and Executive Director, University of Texas Medical Branch Center for Biodefense and Emerging Infectious Diseases. (Galveston, Texas). His work currently focuses heavily on tick-borne diseases. Dr. Walker brings with him significant experience with committee work, as the current chair of the Tick-Borne Disease Research Program's Programmatic Panel, as well as past membership in seven federal advisory committees.
Scott Palmer Commins,* BS, M.D., Ph.D.: Associate Professor of Medicine & Pediatrics, University of North Carolina at Chapel Hill; Member, UNC Food Allergy Initiative, Thurston Research Center (Chapel Hill, North Carolina)
Sam T. Donta,* M.D.: Infectious Disease Consultant, Falmouth Hospital; and Former Member, U.S. Department of Defense Tick Borne Disease Research Programmatic Review Panel (Falmouth, Massachusetts)
Robert Sabatino: Founder and Executive Director, Lyme Society Inc. (Staten Island, New York)
Eugene David Shapiro,* M.D.: Professor of Pediatrics, Epidemiology, and Investigative Medicine, Yale University School of Medicine; Vice Chair for Research of the Department of Pediatrics; Co-Director of Education for the Yale Center for Clinical Investigation; and Deputy Director of Yale's PhD Program in Investigative Medicine (New Haven, Connecticut)
Patricia V. Smith: President, Lyme Disease Association (Wall, New Jersey)
REGULAR GOVERNMENT EMPLOYEES (FEDERAL MEMBERS)
Charles Benjamin (Ben) Beard, Ph.D.: Deputy Director, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention
Commander Rebecca Bunnell,* MPAS, PA-C: Senior Advisor, Learning and Diffusion Group, Innovation Center, Centers for Medicare and Medicaid Services
Angel M. Davey,* Ph.D.: Program Manager, Tick-Borne Disease Research Program, Congressionally Directed Medical Research Programs, U.S. Department of Defense
Dennis M. Dixon, Ph.D.: Chief, Bacteriology and Mycology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Captain Estella Jones, DVM: Deputy Director, Office of Counterterrorism and Emerging Threats, Food and Drug Administration
Leith Jason States,* M.D., MPH (FMF): Deputy Chief Medical Officer, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services
Adalberto (Beto) Pérez de León,* M.S. Ph.D.: Director, Knipling-Bushland U.S. Livestock Insects Research Laboratory, Agricultural Research Service, U.S. Department of Agriculture
* denotes new members
ALTERNATE REGULAR GOVERNMENT EMPLOYEES (FEDERAL MEMBERS)
Chien-Chung Chao, Ph.D.: Research Chemist, Viral and Rickettsial Diseases Department Infectious Diseases Directorate, Naval Medical Research Center, U.S. Department of Defense
Captain Scott J. Cooper, MMSc, PA-C: Senior Technical Advisor and Lead Officer for Medicare Hospital Health and Safety Regulations, Centers for Medicare and Medicaid Services
Shahla Jilani, M.D.: Deputy Chief Medical Officer, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services
David A. Leiby, Ph.D.: Chief, Product Review Branch, Division of Emerging & Transfusion-Transmitted Diseases, Office of Blood Research & Review, Center for Biologics Evaluation & Research, Food and Drug Administration
Commander Todd Myers, Ph.D.: Scientist, Office of the Chief Scientist, Office of Counter Terrorism and Emerging Threats, Food and Drug Administration
Samuel S. Perdue, Ph.D.: Section Chief, Basic Sciences and Program Officer, Rickettsial and Related Diseases, Bacteriology and Mycology Branch, National Institute of Allergy and Infectious Diseases), National Institutes of Health
Susanna N. Visser, Dr.PH,: Associate Director for Policy, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention
###
Link Here